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Measuring the nature and duration of symptoms
of cervical cancer in young women: developing
an interview-based approach
Anita WW Lim1,2*, Lindsay JL Forbes1, Adam N Rosenthal3, Kantipati S Raju4 and Amanda-Jane Ramirez1
Abstract
Background: Some young women experience delays in diagnosis of cervical cancer, but little research about ways
of studying these delays has been published. A major challenge is that gynaecological symptoms are common in
young women, but cervical cancer is rare. This study describes the development and testing of a measure for
studying delays in diagnosis in young women with cervical cancer.
Methods: Prospective development of an interview measure and testing of its ability to reliably and systematically collect
relevant data in two large hospitals in London, UK using 27 women aged 18–40 diagnosed with cervical cancer in the
previous two years. We developed a semi-structured interview schedule and data extraction form to systematically collect
data on symptoms (including nature and duration) and risk factors for delayed diagnosis from young women with cervical
cancer. We piloted the measure among young women with cervical cancer (audiorecording it with their permission),
refining it iteratively. To complete the measure, we developed a database for managing the data and a manual for using
the schedule. Two researchers extracted data from the recorded interviews to assess inter-rater reliability.
Results: The final interview schedule yielded quantitative data on the nature and duration of symptoms and risk factors
for delayed diagnosis. Inter-rater reliability was high. In the pilot, 12 of the 27 women were diagnosed via symptomatic
presentation. Median time from the symptom triggering presentation to presentation was one month (interquartile range
0–4 months). Median time from presentation to diagnosis was three months (interquartile range 1–8.5 months).
Conclusions: We have developed a reliable tool for measuring the nature and duration of symptoms in young women
with cervical cancer. Pilot data suggest that a substantial proportion of women experience delay between first
presentation and diagnosis.
Keywords: Cervical cancer, Early diagnosis, Symptoms
Background
Women under the age of 25 are not offered routine cer-
vical screening in England because of the lack of evi-
dence that screening reduces rates of invasive cancer in
this age group, and the potential harms of unnecessary
treatment [1,2]. While cervical cancer is rare in this age
group (up to about 60 cases a year in England) [3] there
have been reports that a significant proportion of these
young women experience symptoms for some time prior
to diagnosis and significant delays in diagnosis [4], which
are thought to be because either the women or their
health professionals do not recognise the seriousness of
symptoms. Encouraging early presentation and prompt
referral may reduce avoidable deaths and allow for
fertility-sparing treatment options.
Young women commonly present in primary care with
vaginal bleeding, including intermenstrual or postcoital
bleeding, and vaginal discharge [5] and these are far
more likely to be due to contraceptive side-effects or
other conditions such as infections or cervical ectopy
than cancer [5-7]. This means that approaches to en-
courage early presentation and prompt referral of
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women with symptoms suggestive of cervical cancer
must be carefully designed to avoid unnecessary anxiety,
primary care attendances, referrals and investigations.
To inform these approaches we need a better under-
standing of the symptoms experienced by young women
with cervical cancer, what influences the time they take
to seek help and how the symptoms are managed in pri-
mary care. To our knowledge, no universally accepted,
reliable research instruments for collecting systematic
data about the history of presentation of women with
cervical cancer have been published.
Collecting data on the nature and duration of symp-
toms of cancer is challenging because it is necessarily
collected from people recently diagnosed with cancer,
who may be feeling unwell or distressed and may be at-
tending for treatment. Extracting data from medical re-
cords is unreliable because health professionals may
under-record symptoms and may not record onset dates
[8]. Researchers have used semi-structured and in-depth
interviews (telephone or face-to-face) [9-11], and self-
complete questionnaires to collect these data [11,12].
Semi-structured interviews have been shown, when col-
lecting data on nature and duration of symptoms in
other cancer types, to be feasible and acceptable, and to
provide detailed and robust data [9,10]. Although inter-
views are more time-consuming and expensive, they
generally produce higher quality data than self-complete
questionnaires because they allow the interviewer to
check data and probe for information that people might
not have considered relevant. They may also be less dis-
tressing for people dealing with the implications of a
cancer diagnosis and going through anticancer treat-
ment. We have interviewed over 300 women with breast
cancer using this approach, with a very low refusal rate
and no serious adverse events [9,10].
The special challenges of collecting data from young
women with cervical cancer are that they are likely to be
particularly vulnerable because of their age and because
some may be facing difficult treatment decisions involv-
ing a threat to fertility. Many will be living in socioeco-
nomically deprived circumstances [3,13].
The aim of this study was to develop and test a reliable
interview-based measure of the nature and duration of
cervical cancer symptoms and the risk factors for delayed
diagnosis, to be used in a prospective study of all young
women diagnosed with cervical cancer over a one-year
period, and which in turn would inform approaches to
promoting early presentation and prompt onward referral.
Methods
Development of a measure of the nature and duration of
cervical cancer symptoms
The measure comprised a semi-structured interview
schedule, a data extraction form, a database and a
manual. This was similar to a measure that we devel-
oped to examine the nature and duration of symptoms
in breast cancer [9,10], and drew on published studies
and national guidelines about cervical symptoms
[14-22]. We also conducted a focus group to inform the
schedule with four women who had been diagnosed with
cervical cancer in their early thirties.
The purpose of the interview manual was to provide
guidance on how to deliver the interview schedule and
extract data. The data extraction form was used to rec-
ord data during the interview. These data were entered
onto the database for storage and analysis.
We structured the interview to promote accurate re-
call. The interviewer established a rapport with the
woman and allowed the woman to describe key events
at her own pace and in her own way. The woman was
first asked to recount the story of the events leading to
their diagnosis using open questions. The interviewer
then probed to clarify the nature of symptoms including
what the woman thought they were due to, and where
the woman had presented to, if relevant. At this stage,
the interviewer read out a list of symptoms to the
woman, asking if she had experienced any of those in
addition to symptoms previously reported. Symptom
checklists have been shown to elicit symptoms occurring
earlier in the history of presentation among cancer pa-
tients [23].
The interviewer used closed questions to collect data
on dates of onset of symptoms and dates of healthcare
attendances. To promote accurate recall of dates, the
interviewer drew up a calendar timeline working with
the woman to establish the correct chronology [24]. If
the woman could not remember the date or timepoint
of a symptom or healthcare attendance, the interviewer
asked the woman to recall memorable events around
that time such as birthdays, holidays or starting a new
job, and asked the woman when the symptom or health-
care attendance occurred in relation to this, a technique
known as calendar anchoring [25].
If the woman could not provide a date for a particular
symptom onset or other event, the interviewer asked her
to identify the month and year or a range of months for
when it occurred, and whether it was early, middle or
late in the month. If the woman was unable to recall
even a range of months, the interviewer asked her to
identify the season and whether it was early, middle or
end of the season. If the woman could not recall any ap-
proximate dates, the interviewer asked if she could recall
how long she had had the symptom or experienced the
event before diagnosis.
One of the challenges in designing the measure was to
categorise women’s pathways to diagnosis: women with
cervical cancer may have presented many times before
receiving the diagnosis, and there may have been
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referrals between secondary care specialties. A particular
challenge was to define which symptoms were relevant
in a reproducible way; women are likely to have experi-
enced several gynaecological symptoms (some possibly
caused by cancer, and some not) and we considered it
important to make sure that we recorded the most rele-
vant symptoms. Another challenge was to identify repro-
ducibly the key healthcare attendances forming part of
the pathway to diagnosis, because the women may have
attended many times. We therefore developed defini-
tions for pathways to diagnosis, key symptom types and
key healthcare attendances.
Pathways to diagnosis
Each woman was categorised according to her pathway
to diagnosis (see Figure 1):
 Symptomatic presentation – women who presented
to a health professional (doctor, nurse or midwife)
with one of a list of symptoms that could be due to
cervical cancer (known as ‘checklist symptoms’) (see
Additional file 1: Box 1) and that presentation
eventually led to diagnosis (this included women
diagnosed via abnormal cytology if the health
professional carried out a cervical screening test as
part of management of the symptom). We drew up
the checklist drawing on published literature
[17,19-22,26] and the Department of Health key
messages about cervical cancer symptoms [27].
 Abnormality detected on National Health Service
(NHS) Cervical Screening Programme – women
who were diagnosed as a result of an abnormal
finding (abnormal cytology or cervical pathology) on
cervical screening following a routine invitation on
the NHS Cervical Screening Programme (including
women who attended screening because of their
reported symptoms).
 Incidental finding – women who were diagnosed
during procedures or investigations for another
condition or problem (e.g. a suspicious lesion seen
during insertion of an intrauterine device).
Symptom types
We defined three key symptom types:
 the ‘trigger’ symptom - the earliest checklist symp-
tom that led the woman to present to a health pro-
fessional and that led to diagnosis, irrespective of
whether the woman thought it was caused by cer-
vical cancer or not. The trigger symptom was usu-
ally the symptom elicited in response to the
question; “What was the symptom that first
prompted you to see a doctor or nurse?”
 the ‘first attributed’ symptom - the symptom that
the woman believed to be the first symptom of can-
cer at the time of the interview. The first attributed
symptom was usually the symptom the woman re-
ported in answer to the question; “Looking back
now, what would you say was the first sign or symp-
tom of your cancer?” This approach to defining the
first symptom of cancer when collecting data retro-
spectively has been used in some other studies
Figure 1 Pathways to diagnosis and key definitions.
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examining time to diagnosis in cancer [28]. For ex-
ample, a woman may describe attending her GP be-
cause she had intermenstrual bleeding, but at the
time of interview, looking back, she may believe that
postcoital bleeding that she had two months earlier
was due to her cervical cancer. For women diag-
nosed via symptomatic presentation, the trigger
symptom may also have been the first attributed
symptom.
 the ‘initial’ symptom - the first checklist symptom
that a woman reported, but did not attribute to cer-
vical cancer at the time of the interview. For ex-
ample, the same woman above may report vaginal
discharge that started before her postcoital bleeding,
that she attributes to a genital infection.
Healthcare attendances
We defined two key health care attendances: the first at-
tendance and date of diagnosis. Date of diagnosis was
defined as the attendance on which the woman was told
she had cervical cancer (for all women). The first attend-
ance was defined as:
 for women diagnosed via symptomatic presentation,
the first symptomatic presentation for a ‘trigger’
symptom;
 for women diagnosed via the NHS Cervical
Screening Programme, the attendance on which the
first abnormal cervical screening test that led to
diagnosis was carried out;
 for women diagnosed following an incidental
finding, the first attendance in primary or secondary
care that led to diagnosis.
Risk factors for delay
We collected data on risk factors for delay in presenta-
tion, including nature of symptoms, whether or not the
woman thought the symptom was serious at the time,
whether she had children, age of leaving full-time educa-
tion, contraceptive use, reported barriers to symptomatic
presentation, and prior knowledge of cervical cancer.
Most of these were added in the latter stages of inter-
view measure development and were not analysed.
Testing the measure
To test and further develop the measure, we performed
audiorecorded interviews with women aged 18–40 diag-
nosed with cervical cancer in the previous two years, re-
cruited through two London hospitals. Women up to
age 40 were included for pragmatic reasons - cervical
cancer is rare in women aged <25. Potentially eligible
women were identified from a database of women diag-
nosed with gynaecological cancers at each hospital and
were invited to participate via letter. The measure was
refined iteratively after each interview, based on review,
discussion and feedback from a professor of liaison
psychiatry experienced in conducting research interviews
with cancer patients (AJR).
Ethics approval was granted by the South West
London REC3 Ethics Committee. All women provided
written informed consent. Interviews were performed by
the same interviewer (AWWL) either in the woman’s
home or in a private room at the hospital.
To assess interview acceptability, we asked the women
whether they found the questions difficult to understand
or upsetting, and how difficult they found it to remem-
ber the details of the events.
We assessed inter-rater reliability by calculating per-
centage agreement for key interview data for four inter-
views. Two raters listened to interview transcripts and
recorded the nature, severity and attribution of key
symptoms, and the dates of key symptom onset and
healthcare attendances.
The Cervical Cancer History of Presentation Schedule
(CCHOPS)
The interview schedule (see Additional file 2: Appendix
1) included three main domains:
 Symptoms – nature, duration, frequency, severity,
attribution, actions prompted and disclosure to
others
 Timepoints – key symptoms, key healthcare
attendances
 Risk factors – sociodemographic factors, other
health problems, contraception, perception of
primary care, barriers to seeking GP help, cervical
screening history, prior knowledge of cervical cancer
(see Additional file 3: Box 2)
The final interview-based measure (Cervical Cancer
History of Presentation Schedule (CCHOPS)) comprised:
 a semi-structured interview schedule (see Additional
file 2: Appendix 1) – providing a flexible script for
the interviewer that allows for probing and clarifica-
tion of complex histories of presentation,
 a data extraction form - for recording the data items
during the interview (available from the researchers),
 a database – for entering and storing data from the
data extraction form (available from the researchers),
 a manual for interviewers - providing detailed guid-
ance on how to deliver the schedule and extract data
(available from the researchers).
Analysis
A set of rules was used to assign calendar dates for all
approximate timepoints (available from the researchers).
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Patient and provider durations of symptoms were calcu-
lated using figures rounded to the nearest month to
avoid implying accuracy that may be spurious. We cal-
culated medians and interquartile ranges of two types of
duration of symptoms:
 patient-related duration of symptoms, which was the
time from symptom onset (for all three symptom
types) to first attendance,
 provider-related duration of symptoms, which was
the time from first attendance to diagnosis (this
therefore included the time before onward referral
by primary care, and the time spent reaching the
diagnosis in secondary care).
We defined patient delay as a duration of symptoms of
three or more months from each key symptom to first
attendance, and provider delay as duration from first at-
tendance to diagnosis of three or more months, which is
the convention in the cancer literature [29-31].
All statistical analyses were performed using STATA
for Windows (version 11.0, StataCorp LP, College
Station, TX).
Results
Testing the Cervical Cancer History of Presentation
Schedule (CCHOPS) interview-measure and the resultant
exemplar data
Table 1 shows demographic and clinical details of study
participants. We performed interviews with 27 women,
eight in the woman’s home and 19 in a private room at a
hospital. Interviews lasted an average of 35 minutes
(range 11 to 72 minutes).
The women’s median age at diagnosis was 34 years
(interquartile range 28 to 38 years). Two women were
aged under 25 at diagnosis (one 23 and one 24). Most
were White and just over half lived with a partner or
husband. Nearly a third had left school at age 16 or earl-
ier. Twenty-two women had International Federation of
Gynecology and Obstetrics (FIGO) stage 1 cervical can-
cer at diagnosis (nine stage 1a (microinvasive disease)),
four stage 2 and one stage 4.
Pathways to diagnosis
Twelve women were diagnosed via symptomatic presenta-
tion: 11 presented to their GP surgery and one to a sexual
health clinic. Twelve women were diagnosed following ab-
normal cytology or suspicious lesions found during routine
screening on the NHS Cervical Screening Programme.
Three women were diagnosed following an incidental find-
ing: one during an emergency hysterectomy for post-
partum haemorrhage, one during emergency Caesarean
section and one after presenting to a sexual health clinic
for a sexually transmitted infection screen.
Women diagnosed via symptomatic presentation
Of the 12 women who were diagnosed via symptomatic
presentation, seven reported that abnormal vaginal bleed-
ing was the trigger symptom, most commonly intermen-
strual and postcoital bleeding, and the other five presented
with vaginal discharge (n = 3, stages 2a, 2b and 4a), dyspar-
eunia (n = 1, stage 1b1) and abdominal pain (n = 1, stage
1b). Five had had symptoms before the trigger symptom:
three had first attributed symptoms (intermenstrual bleed-
ing, dyspareunia, and vaginal discharge), and two had ini-
tial symptoms (one had intermenstrual bleeding, the other
had postcoital bleeding and dyspareunia).
Table 2 shows the patient durations of symptoms for
the 12 women diagnosed via symptomatic presentation.
Median patient duration of symptoms from the trigger
symptom to first attendance was 1 month (interquartile
range (IQR) 0–4 months). Five delayed presenting with
Table 1 Demographic and clinical characteristics of
participants
Number of
participants (n = 27)
Age at diagnosis
<25 2
25-29 8
30-34 7
≥35 10
Ethnicity
White British or White other 22
Other 5
Living arrangements
Lives with partner/husband ± children 15
Lives with parents 2
Lives with children only 1
Lives with flatmate or alone 7
Missing or refused 2
Age left full-time education
≤16 8
17-18 3
19+ or still studying 16
Cancer stage at diagnosis (FIGO)
1a 13
1b 9
2 4
3 0
4 1
Cancer histology
Squamous cell carcinoma 20
Adenocarcinoma 7
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their trigger symptom for three or more months. Three
of these had abnormal vaginal bleeding (one had inter-
menstrual bleeding and two had postcoital bleeding), the
other two had vaginal discharge and dyspareunia. For
four of these women, the trigger symptom was also the
first attributed symptom.
Two women had a first attributed symptom earlier
than their trigger symptom that started three or more
months before their first attendance: one intermenstrual
bleeding and one dyspareunia.
For one of the two women who reported initial symp-
toms, the time from initial symptom to first attendance
was two years (stage 4a). Her symptoms were postcoital
bleeding and dyspareunia.
Median provider duration of symptoms for the 12
women diagnosed via symptomatic presentation was 3
months (IQR 1–8.5 months, range 0–14 months). For
three women, provider duration of symptoms was less
than one month, for three women one to three months,
and for six women three months or more (for three
women it was twelve months or more). All of the women
with a provider delay had abnormal vaginal bleeding (4 in-
termenstrual bleeding, 3 postcoital bleeding, 1 bleeding
during pregnancy, 2 heavier/longer periods). Three re-
ported vaginal discharge, two dyspareunia and one ab-
dominal pain.
Symptoms in women diagnosed via the NHS Cervical
Screening Programme
Of the 12 women who were diagnosed via the NHS Can-
cer Screening Programme, eight (75%) women reported
symptoms; five first attributed symptoms (vaginal dis-
charge, postcoital bleeding, intermenstrual bleeding,
heavier/longer periods, vaginal discharge, abdominal
pain) and three initial symptoms (vaginal discharge, dys-
pareunia and heavier/longer periods).
Symptoms in women diagnosed as an incidental finding
All three of the women who were diagnosed as an inci-
dental finding had symptoms, all of which included ab-
normal vaginal bleeding. Two of the women had first
attributed symptoms (bleeding during pregnancy, inter-
menstrual bleeding and dyspareunia), and one had an
initial symptom (postcoital bleeding).
Inter-rater reliability
There was 100% agreement on the nature (i.e. postcoital
bleeding, vaginal discharge etc.) and type (i.e. trigger,
first attributed or initial) of key symptoms between the
two raters. There was 100% agreement for three of the
six dates (i.e. date of diagnosis, date of first attendance,
symptom onset dates for trigger, first attributed and ini-
tial) examined. For the other three, there was broad
agreement although the one rater recorded more precise
dates than the other (e.g. rater 1 recorded January 2009,
rater 2 recorded October 2008–March 2009). The net
result was the same in terms of calculating symptom
durations.
Interview acceptability
Almost all women who expressed a view were positive
about their experience of being interviewed and said that
they were keen to provide information that would help
other young women in the future. Three women re-
ported that they found it upsetting to recount the details
of the lead up to their diagnosis or their decision to opt
for non-fertility sparing treatment. Most did not find the
questions difficult to understand. However, most women
said that they found it difficult to remember dates. Two
women showed evidence of psychological distress during
the interviews that was related to the impact of the can-
cer on their mental wellbeing rather than the interview
itself. We made onward referrals for both for psycho-
logical support.
Discussion
We have developed a methodological approach that al-
lows us to collect, collate and analyse data on the nature
and duration of symptoms, and describe the extent of,
and risk factors for, patient and provider delay in young
women with cervical cancer. We have tested this on 27
women and demonstrated that it permits us to collect
meaningful data using reproducible methods. The final
interview schedule is designed to elicit a comprehensive
account of each woman’s history of presentation from
their first symptom that could possibly be due to the
cancer, to the time of diagnosis. The interview itself was
acceptable to the women and did not appear to cause
distress.
A key strength of our study is that we have developed
and tested definitions of the pathways to diagnosis,
Table 2 Duration of symptoms for women diagnosed via
symptomatic presentation (n = 12)*
Duration Patient duration
of symptoms from
trigger symptom
Patient duration of
symptoms that started
before the trigger symptom**
n = 12 n = 5
Trigger Initial First attributed
<1 month 6 1 1
1- < 3 months 1 0 -
3- < 6 months 3 0 -
6- < 12 months 1 0 -
≥12 months 1 1 2
≥3 months 5 (42%) 1 (50%) 2 (67%)
* All durations end at first attendance.
** Only includes key symptoms which started prior to the trigger symptom
(i.e. initial and first attributed). Women may also have had other symptoms
which did not meet key symptom definitions.
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symptom type, durations of symptoms and types of
healthcare attendance. We have produced detailed docu-
mentation to support our methodological approach, in-
cluding an interview schedule, interview manual and a
data extraction form. Our approach is in keeping with
the recommendations made by the Aarhus statement on
early diagnosis research [32]. Our definitions allow sys-
tematic classification of milestones in the woman’s his-
tory of presentation. This was challenging because
pathways to cervical cancer diagnosis are often complex,
and the gynaecological symptoms occur frequently in
young women with non-malignant conditions [19,33,34].
We used several techniques to help promote accurate
recall including a timeline, calendar anchoring, and a
symptom checklist. Similarly, the interview manual and
data extraction schedule promote reproducible data col-
lection as reflected by the high inter-rater reliability
agreement.
The main limitation of our approach is that the meas-
ure is interview-based and therefore, is time-consuming.
Also, our measure of provider delay does not allow us to
examine whether delays occurred in primary as opposed
to secondary care. This is because our measure collects
data from the woman’s point of view and we did not ex-
pect women to know details that would help distinguish
between primary and secondary care delays. Our defin-
ition of the ‘trigger’ symptom as the symptom which led
to diagnosis, may over- or underestimate patient and
provider delays in women who presented with symptoms
which did not lead to diagnosis. Although we were un-
able to present data for some of the risk factors for delay
(due to partial data collection), we are confident that we
have identified those that are likely to be most relevant
to cervical cancer in young women.
Only a small number of women were tested, but our
findings provide some early suggestions that there are
patient and provider delays in diagnosis of cervical can-
cer in young women.
We found some suggestion that among the 12 women
who presented symptomatically, provider delays were
longer than patient delays. For example, one woman
who presented to her GP after two weeks of vaginal dis-
charge was not examined but had a positive pregnancy
test. At six weeks of pregnancy she presented to accident
and emergency with heavy vaginal bleeding, and an
ultrasound was performed to check that the pregnancy
was viable. At 16 weeks, she presented to her GP with a
lump protruding from her vagina and she was referred
to physiotherapy for a suspected prolapse. She was diag-
nosed five months after she first presented, with a stage
2a cancer, following referral from physiotherapy to acci-
dent and emergency and on to gynaecology.
Our planned nationwide study of young women diag-
nosed with symptomatic cancer will use the CCHOPS to
examine time to diagnosis in greater detail. This will
allow us to confirm the preliminary findings identified
during testing.
Conclusion
We have developed a reliable interview-based measure
(Cervical Cancer History of Presentation Schedule) for
use in a nationwide study of delayed diagnosis of cervical
cancer in young women. This will be crucial to enable
us to explore opportunities for earlier intervention,
which might improve the diagnosis of cervical cancer at
earlier stages. The measure can also be used as a model
upon which development of new instruments for sys-
tematically measuring delays in diagnosis in other can-
cers can be based.
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